Dr. Philip A. Efron, Director of the Sepsis and Critical Illness Research Center (SCIRC), recently participated in the 12th Wiggers-Bernard Conference Initiative (March 26–28, 2026) in Vienna, Austria, where global leaders in sepsis research convened to advance pre-clinical modeling standards.
Over two and a half days of intensive collaboration, international experts worked to refine the MQTiPSS 2.0 (Minimum Quality Threshold in Pre-Clinical Sepsis Studies) guidelines. The updated framework is designed to be more concise, clearer, and more impactful—strengthening rigor and reproducibility in sepsis research worldwide.
Dr. Efron also contributed to forward-looking discussions on innovative approaches, including pragmatic clinical trial concepts, reflecting a shared commitment to improving translation from bench to bedside.
The meeting fostered not only meaningful scientific progress but also strong international collaboration, reinforcing a global commitment to advancing sepsis research and improving patient outcomes.
Dr. Efron extends his sincere thanks to the Wiggers-Bernard Initiative and conference host for their leadership, and expresses deep appreciation for the outstanding contributions and collaborative spirit of his colleagues in the field.
